Cite Filings / SPRO / 0000950170-24-090782

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Spero Therapeutics, Inc. Filed 2024-08-05 Acc 0000950170-24-090782

Documents 1

10-Q Quarterly Report , spro-20240630.htm

Around this filing

2024-11-14 10-Q Quarterly Report
2024-08-06 4 CEO and President sold 32,441 shares at an average $1.31 ($42,646)
2024-08-05 S-8 Securities Offered to Employees in Benefit Plans
2024-08-05 8-K Results of operations · Regulation FD disclosure
2024-08-05 10-Q Quarterly Report
2024-05-15 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading spro-20240630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…